Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.89 USD | -0.13% | -0.13% | +2.48% |
Jun. 05 | Trinity Capital Completes Liquidation of Core Scientific Shares | MT |
Jun. 05 | Trinity Capital to Provide $15 Million Funding to Restor3d | MT |
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.48% | 737M | - | ||
-5.31% | 114B | A- | ||
+8.89% | 102B | C+ | ||
+7.51% | 64.37B | - | B+ | |
+20.57% | 63.93B | C | ||
+15.87% | 45.1B | C+ | ||
+12.32% | 42.37B | A- | ||
+20.86% | 35.9B | A- | ||
+7.30% | 25.8B | B | ||
-3.49% | 22.52B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TRIN Stock
- Ratings Trinity Capital Inc.